A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported.

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for Alzheimer’s disease, a new study shows.

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking skills and the ability to perform daily tasks.

The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may reduce the risk of Alzheimer's disease, a new study published Thursday finds.

Compared to other diabetes medications, semaglutide might offer added protection against Alzheimer’s for type 2 diabetes patients.

Type-2 diabetes patients taking the active ingredient in the drugs, semaglutide, "had a significantly lower risk" of developing the disease, the study found

According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the brain and patients with type 2 diabetes.

Ozempic has quickly become a household name with medical researchers claiming the breakthrough drug can have many benefits.

‘What’s the issue?’: Perak MB says Chinese tourists waving their national flag not an offence, cops to determine if they were Malaysians or otherwise The most beautiful brides from the movies 20 very angry-looking cars Former star footballer Abdelaziz Barrada dies at 35 years of age 4-day Deepavali weekend for Hindu civil servants Putin wants peace in Ukraine Revisiting the mistake Trump made that put into question his capability to govern Pahang Sultan's son, Tengku Muhammad marries Tengku Natasya